Changes in serum complement components after 48 weeks of entecavir treatment in hepatitis B cirrhosis patients
ObjectiveTo investigate the effects of entecavir treatment on serum complement components, C3 and C4, in patients with hepatitis B cirrhosis and to determine their relation with treatment response. MethodsNinety-eight patients with hepatitis B cirrhosis who were treated with entecavir (10 mg orally...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2013-05-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5343&ClassID=5416634 |